Reuters logo
BRIEF-Reata Pharmaceuticals reports Q1 loss per share of $0.32
2017年5月11日 / 上午11点23分 / 5 个月前

BRIEF-Reata Pharmaceuticals reports Q1 loss per share of $0.32

May 11 (Reuters) - Reata Pharmaceuticals Inc

* Announces first quarter 2017 financial and operating results

* Q1 loss per share $0.32

* Q1 earnings per share view $-0.13 -- Thomson Reuters I/B/E/S

* Enrolling patients with PH-ILD caused by sarcoidosis, idiopathic pulmonary fibrosis, among others in Lariat trial in Cohort 4

* Anticipate that data from PH-ILD patients in Lariat will be available in second half of 2017 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below